Money · Lobbying reports · 119th Congress
S. 1095
19 saved lobbying reports name S. 1095.
19 reports
Confirmed from the official recordSenate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.
Lobbying Disclosure Act reports, LDA.gov. This copy was read October 7, 2026 at 6:14 PM Eastern.
Reports that name this bill
The amount is what the report gives for the whole quarter: everything the registrant did for that client, all issues together. A linked name opens that organization’s page on this site.
| Registrant | Client | Amount for the whole quarter | Quarter | Report |
|---|---|---|---|---|
| BLUE CROSS AND BLUE SHIELD OF KANSAS, INC. | BLUE CROSS AND BLUE SHIELD OF KANSAS INC | $10,000.00reported as expenses | April to June 2026 | Open the report |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | $890,000.00reported as expenses | April to June 2026 | Open the report |
| BCBSM, INC. | BCBSM INC | $28,000.00reported as expenses | April to June 2026 | Open the report |
| CROSSROADS STRATEGIES, LLC | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | $50,000.00reported as income | April to June 2026 | Open the report |
| BLUECROSS BLUESHIELD OF TENNESSEE | BLUECROSS BLUESHIELD OF TENNESSEE | $140,000.00reported as expenses | April to June 2026 | Open the report |
| FAEGRE DRINKER BIDDLE & REATH LLP | TEVA PHARMACEUTICALS USA, INC. | $60,000.00reported as income | April to June 2026 | Open the report |
| COUNCIL FOR INNOVATION PROMOTION (C4IP) | COUNCIL FOR INNOVATION PROMOTION (C4IP) | $90,000.00reported as expenses | April to June 2026 | Open the report |
| GUIDEWELL MUTUAL HOLDING CORPORATION | GUIDEWELL MUTUAL HOLDING CORPORATION | $20,000.00reported as expenses | April to June 2026 | Open the report |
| BLUE CROSS AND BLUE SHIELD ASSOCIATION | BLUE CROSS AND BLUE SHIELD ASSOCIATION | $990,000.00reported as expenses | April to June 2026 | Open the report |
| PUBLIC CITIZEN | PUBLIC CITIZEN | $99,577.00reported as expenses | April to June 2026 | Open the report |
| NOVARTIS | NOVARTIS | $1,410,000.00reported as expenses | April to June 2026 | Open the report |
| MEHLMAN CONSULTING, INC. | THE CAMPAIGN FOR SUSTAINABLE RX PRICING | $90,000.00reported as income | April to June 2026 | Open the report |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | $7,360,000.00reported as expenses | April to June 2026 | Open the report |
| BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) | BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) | $590,000.00reported as expenses | April to June 2026 | Open the report |
| BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC. | BLUE CROSS AND BLUE SHIELD OF FLORIDA INC | $80,000.00reported as expenses | April to June 2026 | Open the report |
| PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | $3,282,990.00reported as expenses | April to June 2026 | Open the report |
| AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) | AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) | $3,010,000.00reported as expenses | April to June 2026 | Open the report |
| COVINGTON & BURLING LLP | PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC | $220,000.00reported as income | April to June 2026 | Open the report |
| WHITMER & WORRALL, LLC | CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) | $50,000.00reported as income | April to June 2026 | Open the report |